Comparative severity of pediatric osteomyelitis attributable to methicillin-resistant versus methicillin-sensitive

John J Hawkshead1, Nimesh B Patel, Russell W Steele

  • 1Department of Epidemiology, Tulane University School of Public Health & Tropical Medicine, New Orleans, LA 70112, USA. jhawkshe@tulane.edu

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) causes more severe pediatric osteomyelitis, leading to higher fevers, increased inflammation, longer hospital stays, and more surgeries compared to other bacterial causes.

Area of Science:

  • Pediatric Infectious Diseases
  • Orthopedic Surgery
  • Microbiology

Background:

  • Staphylococcus aureus is the leading cause of pediatric hematogenous osteomyelitis.
  • Virulent strains of methicillin-resistant Staphylococcus aureus (MRSA) are increasingly prevalent.
  • It is unclear if MRSA causes more severe illness than methicillin-sensitive strains.

Purpose of the Study:

  • To compare the severity of pediatric hematogenous osteomyelitis caused by MRSA versus other pathogens.
  • To evaluate differences in clinical outcomes based on bacterial etiology.

Main Methods:

  • Retrospective review of 97 pediatric patients with hematogenous osteomyelitis.
  • Comparison of disease severity measures including temperature, acute-phase reactants, hospitalization length, and surgical interventions.

Main Results:

  • MRSA-infected patients showed significantly higher fevers and prolonged elevated temperatures.
  • Increased acute-phase reactants (WBC, CRP, ESR) were observed in MRSA cases.
  • MRSA was associated with longer hospital stays and a greater need for surgical procedures.

Conclusions:

  • MRSA infections result in more severe pediatric osteomyelitis.
  • MRSA-related osteomyelitis necessitates more aggressive medical and surgical management.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...